Stock listing
A1T7BJ Stock Price, News, Filings & Events — Enanta Pharmaceuticals, Inc.
Selected listing: A1T7BJ · LS · EUR · DE
This page tracks Enanta Pharmaceuticals, Inc.'s A1T7BJ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1T7BJ:LS. A1T7BJ:LS is the stock-level entry point for investors researching Enanta Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enanta Pharmaceuticals, Inc. (Ticker: ENTA) is a public company based in the United States, focusing on the development of innovative therapies for viral infections and liver diseases. With a market capitalization of approximately $371.6 million, Enanta is committed to advancing its pipeline of drug candidates to address unmet medical needs. The company is actively engaged in research and development to bring new treatments...
- Ticker
- A1T7BJ:LS
- Asset type
- Stock
- Market cap
- $377.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Enanta Pharmaceuticals, Inc. A1T7BJ:LS stock context
This page tracks Enanta Pharmaceuticals, Inc.'s A1T7BJ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1T7BJ:LS. A1T7BJ:LS is the stock-level entry point for investors researching Enanta Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enanta Pharmaceuticals, Inc. (Ticker: ENTA) is a public company based in the United States, focusing on the development of innovative therapies for viral infections and liver diseases. With a market capitalization of approximately $371.6 million, Enanta is committed to advancing its pipeline of drug candidates to address unmet medical needs. The company is actively engaged in research and development to bring new treatments...
Latest news from Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
August 10, 2026
Entera Announces Second Quarter 2026 Financial Results and Business Updates
August 7, 2026
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute...
June 23, 2026
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial V...
June 19, 2026
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial V...
June 18, 2026
Enanta Pharmaceuticals, Inc. earnings calls
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call
May 6, 2024 · Replay with transcript and chapters
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call
February 7, 2024 · Replay with transcript and chapters
Enanta Pharmaceuticals, Inc. (ENTA) Q4 2023 Earnings Call
November 20, 2023 · Replay with transcript and chapters
Enanta Pharmaceuticals, Inc. (ENTA) Q3 2023 Earnings Call
August 7, 2023 · Replay with transcript and chapters
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2023 Earnings Call
May 8, 2023 · Replay with transcript and chapters
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2023 Earnings Call
February 7, 2023 · Replay with transcript and chapters
Research Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A1T7BJ:LS.
Enanta Pharmaceuticals, Inc. company profile
View the public company page for Enanta Pharmaceuticals, Inc. on 6ix.
Enanta Pharmaceuticals, Inc. news
Read company news and market updates connected to Enanta Pharmaceuticals, Inc..
Enanta Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Enanta Pharmaceuticals, Inc..
Alternate listings
ENTA:NASDAQ
US · USD
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:GETTEX
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
A1T7BJ:LSX
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:TRADEGATE
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
ENTA:BOATS
US · USD
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:MUN
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:BX
CH · CHF
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:DUS
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:FWB
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.
9EP:SWB
DE · EUR
Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LS.